Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

FDA Regulatory Profile

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals appears in FDA public data with 5 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0092-2022, Class I) was initiated on October 12, 2021.

Summary

Total Recalls
5 (2 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0092-2022Class IMethocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC 7133517954)October 12, 2021
D-0256-2022Class IIIButalbital, APAP, Caf 50/325/40 Tablets, packaged in a) 12-count bottles, NDC: 63629-8392-09, barcodSeptember 28, 2021
D-0257-2022Class IIIButalbital, APAP, Caf 50/325/40 Tablet, packaged in a) 12-count bottles, NDC: 71335-1767-09, barcodeSeptember 28, 2021
D-0303-2021Class ISpironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-counJanuary 27, 2021
D-0304-2021Class IISpironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: FrontidaJanuary 27, 2021